Volunteer opportunity: Organizing Phoenix Rising articles
This section contains all the articles that have been published by Phoenix Rising over the years. As you will see if you browse here, some of the articles are outdated--either the research has been superseded or retracted or the article features an event or campaign that is now in...
Discuss the article on the Forums.

Merck’s Zostavax draws new litigation from patients alleging contract Shingles 7/21/17 FiercePharma

Discussion in 'Other Health News and Research' started by *GG*, Jul 27, 2017.

  1. *GG*

    *GG* senior member

    Messages:
    6,256
    Likes:
    4,921
    Concord, NH
    Even as Merck & Co. confronts the prospect of a tough market competitor in GlaxoSmithKline’s Shingrix, the drugmaker’s shingles vaccine Zostavax faces a growing challenge in court.

    Eighteen patients have filed a liability lawsuit against Merck, alleging the company produced and sold an “unreasonably dangerous vaccine” that caused serious injuries after vaccination. Hailing from a range of states including Louisiana, South Carolina, Tennessee, Michigan and Wisconsin, the plaintiffs filed their suit in Merck’s home state of New Jersey.

    cont'd

    http://www.fiercepharma.com/legal/m...jbHhGdCttRkdFcm9FZ1B5VVJNeit6TU5pVFluNmpoVyJ9
     
    Little Bluestem and ScottTriGuy like this.

See more popular forum discussions.

Share This Page